Analysis of more than 400 studies reveals no evidence that delaying the universal hepatitis B vaccine birth dose improves safety or effectiveness.
The analysis draws on data from more than 132 million people.
The universal HBV birth dose has prevented an estimated 90,100 childhood deaths since 1991, but a federal vaccine advisory group may vote to end the practice.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"A delay [in administering the hepatitis B, or HBV, vaccine] will needlessly endanger the health of America’s children, putting more of them at risk of HBV infection."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
